{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:38:38Z","timestamp":1772033918337,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Simple and practical tools for screening high-risk new-onset diabetes after percutaneous coronary intervention (PCI) (NODAP) are urgently needed to improve post-PCI prognosis. We aimed to evaluate the risk factors for NODAP and develop an online prediction tool using conventional variables based on a multicenter database. China evidence-based Chinese medicine database consisted of 249, 987 patients from 4 hospitals in mainland China. Patients\u2009\u2265\u200918 years with implanted coronary stents for acute coronary syndromes and did not have diabetes before PCI were enrolled in this study. According to the occurrence of new-onset diabetes mellitus after PCI, the patients were divided into NODAP and Non-NODAP. After least absolute shrinkage and selection operator regression and logistic regression, the model features were selected and then the nomogram was developed and plotted. Model performance was evaluated by the receiver operating characteristic curve, calibration curve, Hosmer\u2013Lemeshow test and decision curve analysis. The nomogram was also externally validated at a different hospital. Subsequently, we developed an online visualization tool and a corresponding risk stratification system to predict the risk of developing NODAP after PCI based on the model. A total of 2698 patients after PCI (1255 NODAP and 1443 non-NODAP) were included in the final analysis based on the multicenter database. Five predictors were identified after screening: fasting plasma glucose, low-density lipoprotein\u00a0cholesterol, hypertension, family history of diabetes and use of diuretics. And then we developed a web-based nomogram (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/mr.cscps.com.cn\/wscoringtool\/index.html\">https:\/\/mr.cscps.com.cn\/wscoringtool\/index.html<\/jats:ext-link>) incorporating the above conventional factors for predicting patients at high risk for NODAP. The nomogram showed good discrimination, calibration and clinical utility and could accurately stratify patients into different NODAP risks. We developed a simple and practical web-based nomogram based on multicenter database to screen for NODAP risk, which can assist clinicians in accurately identifying patients at high risk of NODAP and developing post-PCI management strategies to improved patient prognosis.<\/jats:p>","DOI":"10.1038\/s41598-024-64430-9","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:08:37Z","timestamp":1718276917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development, validation and visualization of a web-based nomogram for predicting risk of new-onset diabetes after percutaneous coronary intervention"],"prefix":"10.1038","volume":"14","author":[{"given":"Mengmeng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0084-863X","authenticated-orcid":false,"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"20","key":"64430_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1001\/jama.2018.5281","volume":"319","author":"DL Bhatt","year":"2018","unstructured":"Bhatt, D. L. Percutaneous coronary intervention in 2018. JAMA. 319(20), 2127\u20132128. https:\/\/doi.org\/10.1001\/jama.2018.5281 (2018).","journal-title":"JAMA"},{"issue":"14","key":"64430_CR2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jacc.2020.01.056","volume":"75","author":"I Kosmidou","year":"2020","unstructured":"Kosmidou, I. et al. Long-term outcomes in women and men following percutaneous coronary intervention. J. Am. Coll. Cardiol. 75(14), 1631\u20131640. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.056 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"64430_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107689","volume":"34","author":"W-W Chen","year":"2020","unstructured":"Chen, W.-W. et al. Diabetes mellitus associated with an increased risk of percutaneous coronary intervention long-term adverse outcomes in Taiwan: A nationwide population-based cohort study. J. Diabetes Complicat. 34(11), 107689. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107689 (2020).","journal-title":"J. Diabetes Complicat."},{"issue":"6","key":"64430_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234362","volume":"15","author":"CH Lee","year":"2020","unstructured":"Lee, C. H. et al. Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry. PLoS One. 15(6), e0234362. https:\/\/doi.org\/10.1371\/journal.pone.0234362 (2020).","journal-title":"PLoS One"},{"issue":"24","key":"64430_CR5","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jcin.2018.09.033","volume":"11","author":"M Konigstein","year":"2018","unstructured":"Konigstein, M. et al. Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: Analysis from the BIONICS randomized trial. JACC Cardiovasc. Interv. 11(24), 2467\u20132476. https:\/\/doi.org\/10.1016\/j.jcin.2018.09.033 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"issue":"10","key":"64430_CR6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3346\/jkms.2017.32.10.1603","volume":"32","author":"KH Chun","year":"2017","unstructured":"Chun, K. H. et al. Incidence, predictors, and clinical outcomes of new-onset diabetes mellitus after percutaneous coronary intervention with drug-eluting stent. J. Korean Med. Sci. 32(10), 1603\u20131609. https:\/\/doi.org\/10.3346\/jkms.2017.32.10.1603 (2017).","journal-title":"J. Korean Med. Sci."},{"issue":"12","key":"64430_CR7","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.amjcard.2017.03.016","volume":"119","author":"K Ertelt","year":"2017","unstructured":"Ertelt, K. et al. Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI study). Am. J. Cardiol. 119(12), 1917\u20131923. https:\/\/doi.org\/10.1016\/j.amjcard.2017.03.016 (2017).","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"64430_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/1753-0407.13175","volume":"13","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance. J. Diabetes 13(10), 817\u2013826. https:\/\/doi.org\/10.1111\/1753-0407.13175 (2021).","journal-title":"J. Diabetes"},{"issue":"4","key":"64430_CR9","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P. et al. Nomograms in oncology\u2014More than meets the eye. Lancet Oncol. 16(4), e173\u2013e180. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7 (2015).","journal-title":"Lancet Oncol."},{"key":"64430_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.748256","volume":"8","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Development and validation of risk prediction model for new-onset diabetes after percutaneous coronary intervention (NODAP): A study protocol for a retrospective, multicenter analysis. Front. Cardiovasc. Med. 8, 748256. https:\/\/doi.org\/10.3389\/fcvm.2021.748256 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"64430_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jcjd.2015.12.006","volume":"40","author":"Z-F Lin","year":"2016","unstructured":"Lin, Z-F. et al. Statin use and the risk for incident diabetes mellitus in patients with acute coronary syndrome after percutaneous coronary intervention: A population-based retrospective cohort study in Taiwan. Can. J. Diabetes. 40(3), 264\u2013269. https:\/\/doi.org\/10.1016\/j.jcjd.2015.12.006 (2016).","journal-title":"Can. J. Diabetes"},{"issue":"11","key":"64430_CR12","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00125-020-05253-x","volume":"63","author":"S Yuan","year":"2020","unstructured":"Yuan, S. et al. An atlas on risk factors for type 2 diabetes: A wide-angled Mendelian randomisation study. Diabetologia 63(11), 2359\u20132371. https:\/\/doi.org\/10.1007\/s00125-020-05253-x (2020).","journal-title":"Diabetologia"},{"issue":"1","key":"64430_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12902-021-00915-2","volume":"22","author":"DK Song","year":"2022","unstructured":"Song, D. K. et al. Association of serum creatinine levels and risk of type 2 diabetes mellitus in Korea: A case control study. BMC Endocr. Disord. 22(1), 4. https:\/\/doi.org\/10.1186\/s12902-021-00915-2 (2022).","journal-title":"BMC Endocr. Disord."},{"key":"64430_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins, G. S. et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. BMJ. 350, g7594. https:\/\/doi.org\/10.1136\/bmj.g7594 (2015).","journal-title":"BMJ"},{"issue":"04","key":"64430_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3760\/cma.j.cn115791-20210221-00095","volume":"13","author":"Society CD","year":"2021","unstructured":"Society CD. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin. J. Diabetes Mellit. 13(04), 315\u2013409. https:\/\/doi.org\/10.3760\/cma.j.cn115791-20210221-00095 (2021).","journal-title":"Chin. J. Diabetes Mellit."},{"issue":"8","key":"64430_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136354","volume":"10","author":"CS Park","year":"2015","unstructured":"Park, C. S. et al. Acute myocardial infarction is a risk factor for new onset diabetes in patients with coronary artery disease. PLoS One 10(8), e0136354. https:\/\/doi.org\/10.1371\/journal.pone.0136354 (2015).","journal-title":"PLoS One"},{"key":"64430_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1741-7015-9-103","volume":"9","author":"GS Collins","year":"2011","unstructured":"Collins, G. S. et al. Developing risk prediction models for type 2 diabetes: A systematic review of methodology and reporting. BMC Med. 9, 103. https:\/\/doi.org\/10.1186\/1741-7015-9-103 (2011).","journal-title":"BMC Med."},{"key":"64430_CR18","doi-asserted-by":"publisher","first-page":"9108216","DOI":"10.1155\/2020\/9108216","volume":"2020","author":"X Cai","year":"2020","unstructured":"Cai, X. et al. Development and validation of a novel model for predicting the 5-year risk of type 2 diabetes in patients with hypertension: A retrospective cohort study. Biomed. Res. Int. 9108216. https:\/\/doi.org\/10.1155\/2020\/9108216 (2020).","journal-title":"Biomed. Res. Int."},{"key":"64430_CR19","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2147\/DMSO.S304994","volume":"14","author":"X-T Cai","year":"2021","unstructured":"Cai, X.-T. et al. Derivation and validation of a prediction model for predicting the 5-year incidence of type 2 diabetes in non-obese adults: A population-based cohort study. Diabetes Metab. Syndr. Obes. 14, 2087\u20132101. https:\/\/doi.org\/10.2147\/DMSO.S304994 (2021).","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"6","key":"64430_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/1479164116653356","volume":"13","author":"D Sitnik","year":"2016","unstructured":"Sitnik, D. et al. Fasting glucose levels, incident diabetes, subclinical atherosclerosis and cardiovascular events in apparently healthy adults: A 12-year longitudinal study. Diabetes Vasc. Dis. Res. 13(6), 429\u2013437. https:\/\/doi.org\/10.1177\/1479164116653356 (2016).","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"3","key":"64430_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/jdi.13692","volume":"13","author":"C Munekawa","year":"2022","unstructured":"Munekawa, C. et al. Fasting plasma glucose level in the range of 90\u201399 mg\/dL and the risk of the onset of type 2 diabetes: Population-based Panasonic cohort study 2. J. Diabetes Investig. 13(3), 453\u2013459 (2022).","journal-title":"J. Diabetes Investig."},{"issue":"10","key":"64430_CR22","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1001\/archinte.167.10.1068","volume":"167","author":"PWF Wilson","year":"2007","unstructured":"Wilson, P. W. F. et al. Prediction of incident diabetes mellitus in middle-aged adults: The Framingham offspring study. Arch. Intern. Med. 167(10), 1068\u20131074 (2007).","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"64430_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1464-5491.2010.02943.x","volume":"27","author":"WG Gao","year":"2010","unstructured":"Gao, W. G. et al. A simple Chinese risk score for undiagnose ddiabetes. Diabetic Med. J. Br. Diabetic Assoc. 27(3), 274\u2013281 (2010).","journal-title":"Diabetic Med. J. Br. Diabetic Assoc."},{"issue":"15","key":"64430_CR24","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.2018.2525","volume":"319","author":"EP Navarese","year":"2018","unstructured":"Navarese, E. P. et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: A systematic review and meta-analysis. JAMA 319(15), 1566\u20131579 (2018).","journal-title":"JAMA"},{"issue":"9976","key":"64430_CR25","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","volume":"385","author":"J Fulcher","year":"2015","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration et al. Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet 385(9976), 1397\u20131405 (2015).","journal-title":"Lancet"},{"issue":"3","key":"64430_CR26","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.18632\/aging.102763","volume":"12","author":"W Pan","year":"2020","unstructured":"Pan, W. et al. LDL-C plays a causal role on T2DM: A Mendelian randomization analysis. Aging 12(3), 2584\u20132594 (2020).","journal-title":"Aging"},{"issue":"5","key":"64430_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.dsx.2018.04.019","volume":"12","author":"M Janghorbani","year":"2018","unstructured":"Janghorbani, M. et al. Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan diabetes prevention study. Diabetes Metab. Syndr. 12(5), 715\u2013719 (2018).","journal-title":"Diabetes Metab. Syndr."},{"issue":"1","key":"64430_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jdi.13316","volume":"12","author":"L Wei","year":"2021","unstructured":"Wei, L. et al. Low-density lipoprotein cholesterol: High-density lipoprotein cholesterol ratio is associated with incident diabetes in Chinese adults\u2014A retrospective cohort study. J. Diabetes Investig. 12(1), 91\u201398 (2021).","journal-title":"J. Diabetes Investig."},{"issue":"9","key":"64430_CR29","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.bbadis.2019.04.012","volume":"1865","author":"C Perego","year":"2019","unstructured":"Perego, C. et al. Cholesterol metabolism, pancreatic \u03b2-cell function and diabetes. Biochim. Biophys. Acta Mol. Basis Dis. 1865(9), 2149\u20132156 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"45","key":"64430_CR30","doi-asserted-by":"publisher","first-page":"42468","DOI":"10.1074\/jbc.M101419200","volume":"276","author":"PM Yao","year":"2001","unstructured":"Yao, P. M. et al. Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J. Biol. Chem. 276(45), 42468\u201342476 (2001).","journal-title":"J. Biol. Chem."},{"issue":"10","key":"64430_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/1753-0407.13440","volume":"15","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Association between serum LDL-C concentrations and risk of diabetes: A prospective cohort study. J. Diabetes 15(10), 881\u2013889. https:\/\/doi.org\/10.1111\/1753-0407.13440 (2023).","journal-title":"J. Diabetes"},{"issue":"2","key":"64430_CR32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2337\/dc09-0947","volume":"33","author":"K Hemminki","year":"2010","unstructured":"Hemminki, K. et al. Familial risks for type 2 diabetes in Sweden. Diabetes Care\u00a033(2), 293\u2013297. https:\/\/doi.org\/10.2337\/dc09-0947 (2010).","journal-title":"Diabetes Care"},{"issue":"3","key":"64430_CR33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.2897","volume":"46","author":"DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium","year":"2014","unstructured":"DIAbetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium.\u00a0et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46(3), 234\u2013244 (2014).","journal-title":"Nat. Genet."},{"issue":"3","key":"64430_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.117.10546","volume":"71","author":"V Tsimihodimos","year":"2018","unstructured":"Tsimihodimos, V. et al. Hypertension and diabetes mellitus: Coprediction and time trajectories. Hypertension 71(3), 422\u2013428. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10546 (2018).","journal-title":"Hypertension"},{"issue":"2","key":"64430_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijcard.2010.08.041","volume":"153","author":"D Tsiachris","year":"2011","unstructured":"Tsiachris, D. et al. New-onset diabetes and cardiovascular events in essential hypertensives: A 6-year follow-up study. Int. J. Cardiol. 153(2), 154\u2013158. https:\/\/doi.org\/10.1016\/j.ijcard.2010.08.041 (2011).","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"64430_CR36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2337\/db16-0868","volume":"66","author":"RC Aikens","year":"2017","unstructured":"Aikens, R. C. et al. Systolic blood pressure and risk of type 2 diabetes: A Mendelian randomization study. Diabetes 66(2), 543\u2013550. https:\/\/doi.org\/10.2337\/db16-0868 (2017).","journal-title":"Diabetes"},{"issue":"6","key":"64430_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40292-020-00408-8","volume":"27","author":"C Mancusi","year":"2020","unstructured":"Mancusi, C. et al. Insulin resistance the hinge between hypertension and type 2 diabetes. High Blood Press. Cardiovasc. Prev. 27(6), 515\u2013526. https:\/\/doi.org\/10.1007\/s40292-020-00408-8 (2020).","journal-title":"High Blood Press. Cardiovasc. Prev."},{"issue":"6","key":"64430_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346(6), 393\u2013403 (2002).","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"64430_CR39","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/archinternmed.2011.275","volume":"171","author":"T Saito","year":"2011","unstructured":"Saito, T. et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: A randomized controlled trial. Arch. Intern. Med. 171(15), 1352\u20131360 (2011).","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"64430_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/jpbs.JPBS_168_19","volume":"12","author":"SM Sabu","year":"2020","unstructured":"Sabu, S. M. et al. Assessment of association between antihypertensive drug use and occurrence of new-onset diabetes in south Indian patients. J. Pharm. Bioallied Sci. 12(1), 48\u201356. https:\/\/doi.org\/10.4103\/jpbs.JPBS_168_19 (2020).","journal-title":"J. Pharm. Bioallied Sci."},{"key":"64430_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/287696","volume":"2013","author":"C-Y Huang","year":"2013","unstructured":"Huang, C.-Y. et al. A retrospective longitudinal cohort study of antihypertensive drug use and new-onset diabetes in Taiwanese patients. Biomed. Res. Int. 2013, 287696. https:\/\/doi.org\/10.1155\/2013\/287696 (2013).","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"64430_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","volume":"48","author":"AJ Zillich","year":"2006","unstructured":"Zillich, A. J. et al. Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hypertension 48(2), 219\u2013224 (2006).","journal-title":"Hypertension"},{"issue":"2","key":"64430_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11892-018-0976-6","volume":"18","author":"AJ Scheen","year":"2018","unstructured":"Scheen, A. J. Type 2 diabetes and thiazide diuretics. Curr. Diabetes Rep. 18(2), 6 (2018).","journal-title":"Curr. Diabetes Rep."},{"issue":"9","key":"64430_CR44","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder, J. W. et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(9), 3266\u20133281 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"64430_CR45","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/dom.14295","volume":"23","author":"DSH Bell","year":"2021","unstructured":"Bell, D. S. H. & Goncalves, E. Diabetogenic effects of cardioprotective drugs. Diabetes Obes. Metab. 23(4), 877\u2013885. https:\/\/doi.org\/10.1111\/dom.14295 (2021).","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"64430_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","volume":"24","author":"G Mancia","year":"2006","unstructured":"Mancia, G., Grassi, G. & Zanchetti, A. New-onset diabetes and antihypertensive drugs. J. Hypertens. 24(1), 3\u201310. https:\/\/doi.org\/10.1097\/01.hjh.0000194119.42722.21 (2006).","journal-title":"J. Hypertens."},{"issue":"4","key":"64430_CR47","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.amjcard.2013.10.043","volume":"113","author":"K-L Wang","year":"2014","unstructured":"Wang, K.-L. et al. Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy. Am. J. Cardiol. 113(4), 631\u2013636. https:\/\/doi.org\/10.1016\/j.amjcard.2013.10.043 (2014).","journal-title":"Am. J. Cardiol."},{"issue":"9716","key":"64430_CR48","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"Sattar, N. et al. Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials. Lancet 375(9716), 735\u2013742. https:\/\/doi.org\/10.1016\/S0140-6736(09)61965-6 (2010).","journal-title":"Lancet"},{"issue":"Suppl 1","key":"64430_CR49","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.2337\/dc23-S003","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed, N. A. et al. 3. Prevention or delay of type 2 diabetes and associated comorbidities: Standards of care in diabetes-2023. Diabetes Care 46(Suppl 1), S41\u2013S48 (2023).","journal-title":"Diabetes Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64430-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:17:16Z","timestamp":1718277436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-64430-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["64430"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-64430-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13652"}}